AR128475A1 - Polipéptidos y proteínas de fusión con afinidad de unión por tslp - Google Patents

Polipéptidos y proteínas de fusión con afinidad de unión por tslp

Info

Publication number
AR128475A1
AR128475A1 ARP230100294A ARP230100294A AR128475A1 AR 128475 A1 AR128475 A1 AR 128475A1 AR P230100294 A ARP230100294 A AR P230100294A AR P230100294 A ARP230100294 A AR P230100294A AR 128475 A1 AR128475 A1 AR 128475A1
Authority
AR
Argentina
Prior art keywords
polypeptide
tslp
binding
fusion protein
expression vector
Prior art date
Application number
ARP230100294A
Other languages
English (en)
Spanish (es)
Inventor
Anna Edvardsson
Lindvi Gudmundsdotter
Siavash Kijani
Susanne Klint
Original Assignee
Affibody Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affibody Ab filed Critical Affibody Ab
Publication of AR128475A1 publication Critical patent/AR128475A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ARP230100294A 2022-02-08 2023-02-08 Polipéptidos y proteínas de fusión con afinidad de unión por tslp AR128475A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP22155646 2022-02-08

Publications (1)

Publication Number Publication Date
AR128475A1 true AR128475A1 (es) 2024-05-15

Family

ID=80682629

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230100294A AR128475A1 (es) 2022-02-08 2023-02-08 Polipéptidos y proteínas de fusión con afinidad de unión por tslp

Country Status (10)

Country Link
EP (1) EP4476247A1 (https=)
JP (1) JP2025506381A (https=)
KR (1) KR20240139058A (https=)
CN (1) CN118632866A (https=)
AR (1) AR128475A1 (https=)
AU (1) AU2023218534A1 (https=)
CA (1) CA3251231A1 (https=)
IL (1) IL314458A (https=)
MX (1) MX2024009732A (https=)
WO (1) WO2023152144A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2190863B1 (en) 2007-07-31 2015-09-02 Affibody AB New albumin binding compositions, methods and uses
ES2373832T3 (es) 2007-12-19 2012-02-09 Affibody Ab Polipéptido derivado de proteína a y capaz de unirse a pdgf.
CN103003296A (zh) 2010-07-09 2013-03-27 阿菲博迪公司 多肽
WO2014048977A1 (en) 2012-09-25 2014-04-03 Affibody Ab Albumin binding polzpeptide
KR102399024B1 (ko) 2014-06-13 2022-05-17 애피바디 에이비 신규 폴리펩티드
EP3245224B1 (en) * 2015-01-12 2020-07-15 Affibody AB Il-17a-binding polypeptides
CN108290931A (zh) 2015-10-30 2018-07-17 阿菲博迪公司 对pd-l1具有亲和力的新的多肽
WO2021089695A1 (en) * 2019-11-05 2021-05-14 Affibody Ab Polypeptides

Also Published As

Publication number Publication date
JP2025506381A (ja) 2025-03-11
WO2023152144A1 (en) 2023-08-17
CA3251231A1 (en) 2023-08-17
EP4476247A1 (en) 2024-12-18
KR20240139058A (ko) 2024-09-20
MX2024009732A (es) 2024-08-19
IL314458A (en) 2024-09-01
AU2023218534A1 (en) 2024-07-11
CN118632866A (zh) 2024-09-10

Similar Documents

Publication Publication Date Title
AR133787A2 (es) Métodos y composiciones que comprenden polipéptidos recombinantes purificados
WO2021116469A3 (en) Recombinant peptide-mhc complex binding proteins and their generation and use
BR112021021725A2 (pt) Proteínas policlonais recombinantes e métodos de uso das mesmas
CA2283462A1 (en) Vectors having enhanced expression and methods of making and uses thereof
EP4272765A3 (en) Adeno-associated virus (aav) clade f vector and uses therefor
JP2014524241A5 (https=)
AR033980A1 (es) Antigeno de estreptococos
CO2025017440A2 (es) Anticuerpos de dominio único modificados
BR112022016657A2 (pt) Células car-t bcma com atividades melhoradas
JP2020502262A5 (https=)
MX2020007882A (es) Variantes fc con unión mejorada a fcrn y semivida prolongada.
ATE414146T1 (de) Methoden zur herstellung von helpervirusfreien präparationen von freien rekombinenten aav- vektoren mit hohem titer
BR112021026326A2 (pt) Sacarose fosforilase engenheirada, composição, sequência de polinucleotídeo, vetor de expressão, célula hospedeira, e, método para produzir uma sacarose fosforilase engenheirada
BR112023003526A2 (pt) Proteínas de fusão de coronavírus imunogênicos e métodos relacionados
WO2021239838A3 (en) Severe acute respiratory syndrome coronavirus 2 (sars-cov-2) polypeptides and uses thereof for vaccine purposes
BRPI0410562A (pt) molécula recombinante e veìculo para expressão, liberação e purificação de polipeptìdeos alvo
CL2023001433A1 (es) Muteína de il-2; proteína de fusión; ácido nucleico; vector; célula hospedera; métodos; uso
AR083586A1 (es) Peptidos del factor viii (fviii) para la induccion de tolerancia inmune y para inmunodiagnostico
BR112018076674A2 (pt) proteína de fusão entre o fator de viabilidade do cone derivado de bastonetes de forma curta e um peptídeo hidrofílico
AR128475A1 (es) Polipéptidos y proteínas de fusión con afinidad de unión por tslp
WO2021252406A3 (en) Method for selecting antibody fragments, recombinant antibodies produced therefrom, and uses thereof
AU2019356414A8 (en) Binding proteins specific for HA-1H and uses thereof
DK200601181A (da) Fiskevaccine
DE60028248D1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
ATE449790T1 (de) Rekombinante gelatinepartikel für die zelladhäsion